See also this year's filing and all EDGAR filings for this company.
PDF Report 0001023024_2021_ANI_Pharmaceuticals_INC.pdf
Logs
| warning | The EntityCommonStockSharesOutstanding does not exist | industry.us_generic | {} |
Graph
Absolute values for 0001023024, ANI Pharmaceuticals INC
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 170,321,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 192,091,000 |
| 2 | PropertyPlantAndEquipmentNet | 41,269,000 |
| 3 | remainder_Assets | 57,509,000 |
| 4 | LiabilitiesCurrent | 78,565,000 |
| 5 | LiabilitiesNoncurrent | 186,925,000 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 98,577,409 |
| 8 | SellingGeneralAndAdministrativeExpense | 89,306,062 |
| 9 | ResearchAndDevelopmentExpense | 16,762,279 |
| 10 | remainder_Expenses | 55,071,787 |
| 11 | remainder_Revenues | 214,033,916 |
| 12 | remainder_NetIncome | -10,115,490 |
| 13 | remainder_ComprehensiveNetIncome | -9,350,507 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 461,190,000 |
| 1 | Liabilities | 265,490,000 |
| 2 | Expenses | 259,717,537 |
| 3 | Revenues | 214,033,916 |
| 4 | StockholdersEquity | 195,700,000 |
| 5 | NetIncome | -55,799,111 |
| 6 | ComprehensiveNetIncome | -60,474,364 |
| 7 | BaseVar | 609,948,725 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 1.01 |
| 9 | EconomicCapitalRatio | 2.31 |
Edgar->Model Mapping
Feature Distribution
Change over Time
